Senti Biosciences Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Senti Biosciences Stock Summary

Senti Biosciences competes with Cadrenal Therapeutics,, Foghorn Therapeutics, Quoin Pharmaceuticals, Cingulate, and Lipella Pharmaceuticals. Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. The company was incorporated in 2016 and is headquartered in South San Francisco, California. Senti Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 89 people.

Senti Biosciences Key Financial Ratios

Senti Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Senti Biosciences's current stock value. Our valuation model uses many indicators to compare Senti Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Senti Biosciences competition to find correlations between indicators driving Senti Biosciences's intrinsic value. More Info.Senti Biosciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, Senti Biosciences' Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Senti Biosciences' earnings, one of the primary drivers of an investment's value.

Senti Biosciences Systematic Risk

Today, most investors in Senti Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Senti Biosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Senti Biosciences growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Senti Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Senti Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Senti Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Senti Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Senti Biosciences's daily price indicators and compare them against related drivers.

When running Senti Biosciences' price analysis, check to measure Senti Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senti Biosciences is operating at the current time. Most of Senti Biosciences' value examination focuses on studying past and present price action to predict the probability of Senti Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senti Biosciences' price. Additionally, you may evaluate how the addition of Senti Biosciences to your portfolios can decrease your overall portfolio volatility.